BLP has advised IDB Invest, a member of the IDB Group, in the granting of a loan of $14 million to Calox de Costa Rica S.A. (Calox). The loan enables Calox to obtain substantial improvements in its productive capacities and seek international certifications that validate the quality of its products, affording access to new markets. It also increases the company’s capacity to expand its manufacturing, replacing imports and diversifying its product portfolio. The project loan has two main objectives. The first is to acquire the existing plant to improve infrastructure and energy efficiency, enabling certification, and expand its production capacity in the medium term. The second goal is to provide medium-term financing for working capital. This will allow Calox to boost its brand of medications, expand its market to South America, meet additional needs resulting from the COVID-19 pandemic, and continue with the research and development of new products.